Command Palette

Search for a command to run...

ACCPL
58.7(+0.00%)
1W: -0.51%

Accretion Pharmaceuticals Peer Comparison

Snapshot Summary

Accretion Pharmaceuticals Ltd. is in a competitive pharmaceutical landscape with peers showing varied strengths in growth, profitability, and valuation. Companies like Dr. Reddy's Laboratories and Cipla stand out for their profitability, while firms like Divi's Laboratories show concerning growth metrics. Overall, the analysis reveals a mix of strong performers and financially risky companies, indicating a need for careful selection in the sector.

  • Dr. Reddy's Laboratories and Cipla lead in profitability metrics.
  • Divi's Laboratories shows disappointing growth rates, indicating potential financial stress.
  • Cipla and Dr. Reddy's Laboratories are top value picks with low PE ratios and strong margins.
  • Dr. Reddy's Laboratories Ltd.: Highest ROE and ROCE, strong EPS growth, and low PE ratio.
  • Cipla Ltd.: High profitability with solid ROA and ROE, attractive valuation metrics.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
ZYDUSLIFE₹990.65₹99,682.17Cr17.2624.90%0.04

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.